AETHLON MEDICAL, INC. (AEMD) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 1.04M USD | Liabilities, Current |
| Cash and equivalents | 4.93M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.04M | $4.93M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $1.45M | $5.03M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $1.26M | $6.96M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $1.40M | $5.85M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $1.63M | $3.77M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $1.90M | $5.50M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $1.77M | $4.83M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $2.33M | $6.86M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $2.13M | $9.07M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $1.83M | $5.44M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $2.10M | $7.97M | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $1.71M | $10.18M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $1.82M | $12.90M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $1.51M | $14.53M | (m) | $0.00 | (m) | (m) |
| 2022-12-31 | (m) | $2.44M | $17.50M | (m) | $0.00 | (m) | (m) |
| 2022-09-30 | (m) | $2.10M | $19.60M | (m) | $114.85K | (m) | (m) |
| 2022-06-30 | (m) | $1.64M | $14.92M | (m) | $114.85K | (m) | (m) |
| 2022-03-31 | (m) | $1.82M | (m) | (m) | $127.97K | (m) | (m) |
| 2021-12-31 | (m) | $1.07M | (m) | (m) | $131.97K | (m) | (m) |
| 2021-09-30 | (m) | $974.35K | (m) | (m) | $131.97K | (m) | (m) |
| 2021-06-30 | (m) | $1.13M | (m) | (m) | $131.97K | (m) | (m) |
| 2021-03-31 | (m) | $1.38M | $9.86M | (m) | $149.08K | (m) | (m) |
| 2020-12-31 | (m) | $1.24M | $12.13M | (m) | $114.85K | (m) | (m) |
| 2020-09-30 | (m) | $1.49M | (m) | (m) | $111.85K | (m) | (m) |
| 2020-06-30 | (m) | $1.22M | (m) | (m) | $206.73K | (m) | (m) |
| 2020-03-31 | (m) | $1.07M | (m) | (m) | $206.73K | (m) | (m) |
| 2019-12-31 | (m) | $810.61K | (m) | (m) | $206.73K | (m) | (m) |
| 2019-09-30 | (m) | $1.17M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $1.80M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $1.82M | (m) | (m) | $0.00 | (m) | (m) |
| 2018-12-31 | (m) | $1.78M | (m) | (m) | $0.00 | (m) | (m) |
| 2018-09-30 | (m) | $1.26M | (m) | (m) | $0.00 | (m) | (m) |
| 2018-06-30 | (m) | $471.46K | (m) | (m) | $74.81K | (m) | (m) |
| 2018-03-31 | (m) | $477.96K | (m) | (m) | $74.81K | (m) | (m) |
| 2017-12-31 | (m) | $336.41K | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $345.94K | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $408.31K | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $611.76K | (m) | (m) | $0.00 | (m) | (m) |
| 2016-12-31 | (m) | $374.12K | (m) | (m) | $0.00 | (m) | (m) |
| 2016-09-30 | (m) | $1.08M | (m) | (m) | $193.72K | (m) | (m) |
| 2016-06-30 | (m) | $468.96K | (m) | (m) | $0.00 | (m) | (m) |
| 2016-03-31 | (m) | $526.61K | (m) | (m) | $199.47K | (m) | (m) |
| 2015-12-31 | (m) | $883.89K | (m) | (m) | $1.67K | (m) | (m) |
| 2015-09-30 | (m) | $828.95K | (m) | (m) | $186.81K | (m) | (m) |
| 2015-06-30 | (m) | $896.61K | (m) | (m) | $967.00 | (m) | (m) |
| 2015-03-31 | (m) | $573.98K | (m) | (m) | $193.34K | (m) | (m) |
| 2014-12-31 | (m) | $1.60M | (m) | (m) | $15.23K | (m) | (m) |
| 2014-09-30 | (m) | $3.39M | (m) | (m) | $258.67K | (m) | (m) |
| 2014-06-30 | (m) | $3.66M | (m) | (m) | $11.10K | (m) | (m) |
| 2014-03-31 | (m) | $15.65M | (m) | (m) | $95.18K | (m) | (m) |
| 2013-12-31 | (m) | $12.65M | (m) | (m) | $45.01K | (m) | (m) |
| 2013-09-30 | (m) | $11.96M | (m) | (m) | $220.19K | (m) | (m) |
| 2013-06-30 | (m) | $9.02M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $9.64M | (m) | (m) | $208.78K | (m) | (m) |
| 2012-12-31 | (m) | $7.63M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | $8.95M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $9.21M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $10.13M | (m) | (m) | $400.11K | (m) | (m) |
| 2011-12-31 | (m) | $7.01M | (m) | (m) | $183.37K | (m) | (m) |
| 2011-09-30 | (m) | $6.66M | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $7.03M | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | $6.54M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |